<DOC>
	<DOC>NCT02307591</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.</brief_summary>
	<brief_title>Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hemorrhagic Fever, Ebola</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>patient admitted to the Emergency ETC at Goderich with a clinical diagnosis of Ebola virus disease; patient who consent to participate in the study. negative RTPCR tests for Ebola virus age &lt;2 years state of shock upon admission onset of fever for more than 6 days Glasgow Coma Scale &lt;12 known contraindications to administration of amiodarone positive for HIV antibodies.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>